Monday, November 23, 2009

H1N1 Vaccine Trial in HIV Positive Individuals

Researchers at the University of Florida Center for HIV/AIDS Research are currently conducting a national clinical trial on the 2009 H1N1 vaccine in HIV positive individuals. People with HIV are included in the list of high risk groups that are more vulnerable to complications from the flu due to their immunocompromised state.

The researchers aim to find out whether a higher-than-usual dose of vaccine will trigger a protective immune response in these individuals. Currently, adults have been shown to respond to only one dose of the vaccine, and this study is investigating whether HIV positive patients will have an immune response to one dose as well, or whether they will need two. The researchers will also be looking at how strong the immune response is in these individuals as well as how long the response lasts.

For more information on the trial, visit

No comments: